TABLE 3:

Peak enhancement phase on dynamic curves*

GroupCenterPeriphery
Patients before treatment6.0 ± 1.77.5 ± 2.5
Patients after treatment4.2 ± 2.65.4 ± 3.1
Control subjects4.0 ± 1.44.2 ± 1.4
  • * Data are the mean ± SD.

  • P < .01, compared with posttreatment and control values.